2014
DOI: 10.1038/cti.2014.2
|View full text |Cite
|
Sign up to set email alerts
|

Accelerating immune reconstitution after hematopoietic stem cell transplantation

Abstract: Viral infections remain a significant cause of morbidity and mortality after hematopoietic stem cell transplantation. Pharmacologic agents are effective against some pathogens, but they are costly and can be associated with significant toxicities. Thus, many groups have investigated adoptive T-cell transfer as a means of hastening immune reconstitution and preventing and treating viral infections. This review discusses the immunotherapeutic strategies that have been explored.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

3
5
0

Year Published

2015
2015
2017
2017

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 94 publications
(140 reference statements)
3
5
0
Order By: Relevance
“…Although engraftment occurs within a few weeks and total blood populations N p and N d (and often immune function) re-establish themselves within a few months after successful HSC transplant [ 43 , 44 ], it is still surprising that the clone size distribution is relatively static within each animal (see Additional file 1 for other animals). Given the observed stationarity, we will use the steady-state results of our mathematical model (explicitly derived in Additional file 1 ) for fitting data from each animal.…”
Section: Resultsmentioning
confidence: 99%
“…Although engraftment occurs within a few weeks and total blood populations N p and N d (and often immune function) re-establish themselves within a few months after successful HSC transplant [ 43 , 44 ], it is still surprising that the clone size distribution is relatively static within each animal (see Additional file 1 for other animals). Given the observed stationarity, we will use the steady-state results of our mathematical model (explicitly derived in Additional file 1 ) for fitting data from each animal.…”
Section: Resultsmentioning
confidence: 99%
“…T‐cell reactivity is directed towards a wide range of CMV antigens, and natural killer cells typically increase in response to viral replication 13 , 14 . Adoptive transfer of CMV‐specific T‐cell lines demonstrates promising results in hematopoietic stem cell transplantation (HSCT) recipients 15 , 16 . However, generation of specific T‐cell lines ex vivo and their function in vivo is more complicated in SOT recipients and success has not been achieved previously—a single case report describes generation of CMV‐specific T‐cell lines from a patient with GRCMV disease, however the patient did not survive long term.…”
mentioning
confidence: 99%
“…13,14 Adoptive transfer of CMV-specific T-cell lines demonstrates promising results in hematopoietic stem cell transplantation (HSCT) recipients. 15,16 However, generation of specific T-cell lines ex vivo and their function in vivo is more complicated in SOT recipients and success has not been achieved previously-a single case report describes generation of CMV-specific T-cell lines from a patient with GRCMV disease, however the patient did not survive long term. 17 In HSCT, peripheral blood mononuclear cells (PBMCs) taken as starting material for CMV-specific T-cell generation are derived from healthy donors.…”
mentioning
confidence: 99%
“…Although engraftment occurs within a few weeks and total blood populations N p and N d (and often immune function) re-establish themselves within a few months after successful HSC transplant [43,44], it is still surprising that the clone sizedistribution is relatively static within each animal (see Additional File for other animals). Given the observed stationarity, we will use the steady-state results of our mathematical model (explicitly derived in the Additional File) for fitting data from each animal.…”
Section: Results and Analysismentioning
confidence: 99%